National Research Corp Net Income
| NRC Stock | USD 14.56 0.81 5.27% |
As of the 11th of February 2026, National Research secures the Downside Deviation of 5.38, mean deviation of 2.76, and Risk Adjusted Performance of 0.0379. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of National Research Corp, as well as the relationship between them.
National Research Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 3.0776 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 11.6 M | 15.6 M | |
| Net Income Applicable To Common Shares | 36.6 M | 20.5 M | |
| Net Income From Continuing Ops | 28.5 M | 28.1 M | |
| Net Income Per Share | 0.52 | 0.67 | |
| Net Income Per E B T | 0.65 | 0.56 |
National | Net Income | Build AI portfolio with National Stock |
Analyzing National Research's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing National Research's current valuation and future prospects.
Latest National Research's Net Income Growth Pattern
Below is the plot of the Net Income of National Research Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in National Research Corp financial statement analysis. It represents the amount of money remaining after all of National Research Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is National Research's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in National Research's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 11.6 M | 10 Years Trend |
|
Net Income |
| Timeline |
National Net Income Regression Statistics
| Arithmetic Mean | 21,912,927 | |
| Geometric Mean | 17,333,613 | |
| Coefficient Of Variation | 46.96 | |
| Mean Deviation | 8,514,421 | |
| Median | 20,518,000 | |
| Standard Deviation | 10,290,878 | |
| Sample Variance | 105.9T | |
| Range | 37M | |
| R-Value | 0.49 | |
| Mean Square Error | 86.3T | |
| R-Squared | 0.24 | |
| Significance | 0.05 | |
| Slope | 989,201 | |
| Total Sum of Squares | 1694.4T |
National Net Income History
Other Fundumenentals of National Research Corp
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
National Research Net Income component correlations
National Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for National Research is extremely important. It helps to project a fair market value of National Stock properly, considering its historical fundamentals such as Net Income. Since National Research's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of National Research's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of National Research's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Providers & Services sector continue expanding? Could National diversify its offerings? Factors like these will boost the valuation of National Research. Anticipated expansion of National directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every National Research data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.71) | Dividend Share 0.52 | Earnings Share 0.47 | Revenue Per Share | Quarterly Revenue Growth (0.05) |
Understanding National Research Corp requires distinguishing between market price and book value, where the latter reflects National's accounting equity. The concept of intrinsic value - what National Research's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push National Research's price substantially above or below its fundamental value.
It's important to distinguish between National Research's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding National Research should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, National Research's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
National Research 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to National Research's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of National Research.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in National Research on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding National Research Corp or generate 0.0% return on investment in National Research over 90 days. National Research is related to or competes with Sophia Genetics, Viemed Healthcare, Spok Holdings, TruBridge, Nano X, Definitive Healthcare, and Health Catalyst. National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient... More
National Research Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure National Research's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess National Research Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.38 | |||
| Information Ratio | 0.0146 | |||
| Maximum Drawdown | 27.21 | |||
| Value At Risk | (4.27) | |||
| Potential Upside | 5.17 |
National Research Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for National Research's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as National Research's standard deviation. In reality, there are many statistical measures that can use National Research historical prices to predict the future National Research's volatility.| Risk Adjusted Performance | 0.0379 | |||
| Jensen Alpha | 0.0921 | |||
| Total Risk Alpha | (0.28) | |||
| Sortino Ratio | 0.011 | |||
| Treynor Ratio | 0.235 |
National Research February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0379 | |||
| Market Risk Adjusted Performance | 0.245 | |||
| Mean Deviation | 2.76 | |||
| Semi Deviation | 5.07 | |||
| Downside Deviation | 5.38 | |||
| Coefficient Of Variation | 2681.06 | |||
| Standard Deviation | 4.08 | |||
| Variance | 16.63 | |||
| Information Ratio | 0.0146 | |||
| Jensen Alpha | 0.0921 | |||
| Total Risk Alpha | (0.28) | |||
| Sortino Ratio | 0.011 | |||
| Treynor Ratio | 0.235 | |||
| Maximum Drawdown | 27.21 | |||
| Value At Risk | (4.27) | |||
| Potential Upside | 5.17 | |||
| Downside Variance | 28.96 | |||
| Semi Variance | 25.7 | |||
| Expected Short fall | (2.48) | |||
| Skewness | (2.16) | |||
| Kurtosis | 8.72 |
National Research Corp Backtested Returns
National Research Corp has Sharpe Ratio of close to zero, which conveys that the firm had a close to zero % return per unit of risk over the last 3 months. National Research exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify National Research's Risk Adjusted Performance of 0.0379, downside deviation of 5.38, and Mean Deviation of 2.76 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.6, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, National Research's returns are expected to increase less than the market. However, during the bear market, the loss of holding National Research is expected to be smaller as well. At this point, National Research Corp has a negative expected return of -0.0014%. Please make sure to verify National Research's expected short fall, and the relationship between the value at risk and daily balance of power , to decide if National Research Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.56 |
Good reverse predictability
National Research Corp has good reverse predictability. Overlapping area represents the amount of predictability between National Research time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of National Research Corp price movement. The serial correlation of -0.56 indicates that roughly 56.0% of current National Research price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.56 | |
| Spearman Rank Test | 0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 4.68 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
National Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, National Research Corp reported net income of 11.6 M. This is 96.6% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 97.97% higher than that of the company.
National Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses National Research's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of National Research could also be used in its relative valuation, which is a method of valuing National Research by comparing valuation metrics of similar companies.National Research is currently under evaluation in net income category among its peers.
National Research ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, National Research's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to National Research's managers, analysts, and investors.Environmental | Governance | Social |
National Research Institutional Holders
Institutional Holdings refers to the ownership stake in National Research that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of National Research's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing National Research's value.| Shares | Bank Of New York Mellon Corp | 2025-06-30 | 204.6 K | Aqr Capital Management Llc | 2025-06-30 | 201.4 K | Willis Investment Counsel | 2025-06-30 | 181 K | Wells Fargo & Co | 2025-06-30 | 169.9 K | Creative Planning Inc | 2025-06-30 | 147.4 K | Northwest & Ethical Investments L.p. | 2025-06-30 | 129.2 K | Bank Of America Corp | 2025-06-30 | 122.3 K | Charles Schwab Investment Management Inc | 2025-06-30 | 111 K | Citadel Advisors Llc | 2025-06-30 | 107.2 K | Kayne Anderson Rudnick Investment Management Llc | 2025-06-30 | 3 M | Blackrock Inc | 2025-06-30 | 1.2 M |
National Fundamentals
| Return On Equity | 0.51 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 404.49 M | ||||
| Shares Outstanding | 22.64 M | ||||
| Shares Owned By Insiders | 48.48 % | ||||
| Shares Owned By Institutions | 49.21 % | ||||
| Number Of Shares Shorted | 382.04 K | ||||
| Price To Earning | 26.72 X | ||||
| Price To Book | 24.87 X | ||||
| Price To Sales | 2.40 X | ||||
| Revenue | 137.39 M | ||||
| Gross Profit | 85.02 M | ||||
| EBITDA | 30.23 M | ||||
| Net Income | 11.6 M | ||||
| Cash And Equivalents | 32.97 M | ||||
| Cash Per Share | 1.33 X | ||||
| Total Debt | 79.03 M | ||||
| Debt To Equity | 0.37 % | ||||
| Current Ratio | 1.31 X | ||||
| Book Value Per Share | 0.62 X | ||||
| Cash Flow From Operations | 26.45 M | ||||
| Short Ratio | 4.67 X | ||||
| Earnings Per Share | 0.47 X | ||||
| Price To Earnings To Growth | 3.42 X | ||||
| Number Of Employees | 368 | ||||
| Beta | 0.5 | ||||
| Market Capitalization | 329.89 M | ||||
| Total Asset | 134.88 M | ||||
| Retained Earnings | (17.3 M) | ||||
| Working Capital | (16.26 M) | ||||
| Current Asset | 27.6 M | ||||
| Current Liabilities | 12.83 M | ||||
| Annual Yield | 0.04 % | ||||
| Five Year Return | 1.24 % | ||||
| Net Asset | 134.88 M | ||||
| Last Dividend Paid | 0.52 |
About National Research Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National Research Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National Research using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National Research Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether National Research Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Research's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Research Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Research Corp Stock:Check out You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Will Health Care Providers & Services sector continue expanding? Could National diversify its offerings? Factors like these will boost the valuation of National Research. Anticipated expansion of National directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every National Research data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.71) | Dividend Share 0.52 | Earnings Share 0.47 | Revenue Per Share | Quarterly Revenue Growth (0.05) |
Understanding National Research Corp requires distinguishing between market price and book value, where the latter reflects National's accounting equity. The concept of intrinsic value - what National Research's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push National Research's price substantially above or below its fundamental value.
It's important to distinguish between National Research's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding National Research should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, National Research's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.